Literature DB >> 18058792

Pharmacokinetics of selected chiral flavonoids: hesperetin, naringenin and eriodictyol in rats and their content in fruit juices.

Jaime A Yáñez1, Connie M Remsberg, Nicole D Miranda, Karina R Vega-Villa, Preston K Andrews, Neal M Davies.   

Abstract

The majority of pharmacokinetic studies of individual flavonoids or after ingestion of foodstuffs have overlooked the chirality of some of these xenobiotics. In order to characterize for the first time the stereoselective pharmacokinetics of three flavonoids, hesperetin, naringenin and eriodictyol were intravenously administered (20 mg/kg) to male Sprague-Dawley rats, and their stereospecific content was assessed in various fruit juices. Concentrations in serum, urine and fruit juices were characterized via HPLC and verified by LC/MS. Short half-lives (3-7 h) in serum were observed, while a better estimation of half-life (12-48 h) and the other pharmacokinetic parameters was observed using urinary data. The three flavonoids are predominantly excreted via non-renal routes (fe values of 3-7%), and undergo rapid and extensive phase II metabolism. The (2S)-epimers of the flavonoid glycosides and the S(-)-enantiomers of the aglycones were predominant and in some instances the organic fruit juices had higher concentrations than the conventional fruit juices. This study reports for the first time the stereospecific pharmacokinetics of three chiral flavonoids and their stereospecific content in fruit juices. It also reports for the first time the stereospecific pharmacokinetics of flavonoids employing urine as a more reliable biological matrix. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18058792     DOI: 10.1002/bdd.588

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  15 in total

1.  Evaluation of topical hesperetin matrix film for back-of-the-eye delivery.

Authors:  Goutham R Adelli; Tushar Hingorani; Nagendra Punyamurthula; Sai Prachetan Balguri; Soumyajit Majumdar
Journal:  Eur J Pharm Biopharm       Date:  2015-02-26       Impact factor: 5.571

2.  Identification of Naringin Metabolites in Human Urine and Feces.

Authors:  Xuan Zeng; Yang Bai; Wei Peng; Weiwei Su
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-08       Impact factor: 2.441

3.  Hesperidin Bioavailability Is Increased by the Presence of 2S-Diastereoisomer and Micronization-A Randomized, Crossover and Double-Blind Clinical Trial.

Authors:  Anna Crescenti; Antoni Caimari; Juan María Alcaide-Hidalgo; Roger Mariné-Casadó; Rosa M Valls; Judit Companys; Patricia Salamanca; Lorena Calderón-Pérez; Laura Pla-Pagà; Anna Pedret; Antoni Delpino-Rius; Pol Herrero; Iris Samarra; Lluís Arola; Rosa Solà; Josep M Del Bas
Journal:  Nutrients       Date:  2022-06-15       Impact factor: 6.706

4.  An NADH-Dependent Reductase from Eubacterium ramulus Catalyzes the Stereospecific Heteroring Cleavage of Flavanones and Flavanonols.

Authors:  Annett Braune; Michael Gütschow; Michael Blaut
Journal:  Appl Environ Microbiol       Date:  2019-09-17       Impact factor: 4.792

5.  Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells.

Authors:  Yong Yang; Joy Wolfram; Kathryn Boom; Xiaohong Fang; Haifa Shen; Mauro Ferrari
Journal:  Cell Biochem Funct       Date:  2012-10-08       Impact factor: 3.685

6.  Enhancement of naringenin bioavailability by complexation with hydroxypropyl-β-cyclodextrin. [corrected].

Authors:  Maria Shulman; Merav Cohen; Alejandro Soto-Gutierrez; Hiroshi Yagi; Hongyun Wang; Jonathan Goldwasser; Carolyn W Lee-Parsons; Ofra Benny-Ratsaby; Martin L Yarmush; Yaakov Nahmias
Journal:  PLoS One       Date:  2011-04-06       Impact factor: 3.240

7.  Production of hesperetin glycosides by Xanthomonas campestris and cyclodextrin glucanotransferase and their anti-allergic activities.

Authors:  Kei Shimoda; Hiroki Hamada
Journal:  Nutrients       Date:  2010-02-09       Impact factor: 5.717

8.  Pharmacological characterization of liquiritigenin, a chiral flavonoid in licorice.

Authors:  Samaa Alrushaid; Neal M Davies; Stephanie E Martinez; Casey L Sayre
Journal:  Res Pharm Sci       Date:  2016-10

9.  Eriodictyol Attenuates Myocardial Ischemia-Reperfusion Injury through the Activation of JAK2.

Authors:  Defang Li; Ning Lu; Jichun Han; Xiaoyu Chen; Wenjin Hao; Wenjuan Xu; Xiaona Liu; Lei Ye; Qiusheng Zheng
Journal:  Front Pharmacol       Date:  2018-01-30       Impact factor: 5.810

Review 10.  Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin Bioavailability.

Authors:  Anna Mas-Capdevila; Joan Teichenne; Cristina Domenech-Coca; Antoni Caimari; Josep M Del Bas; Xavier Escoté; Anna Crescenti
Journal:  Nutrients       Date:  2020-05-20       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.